RTK Group

RTK Group is a family office-backed biopharmaceutical advisory and investment fund focused on supporting companies developing emerging technologies that have a disruptive impact and significant potential to benefit patients. We focus our efforts where we can leverage our unique expertise in company formation and technology development to assist high‐performing management teams realize the full value potential of their technology. We embrace scientific risk and support research with high-impact potential. Our belief is that investing in promising concepts backed by solid science creates the potential for significant value creation. Our ultimate goal is to improve the human condition through our support of technology development. Leaving the potential for a better future for our future generations is what motivates us to foster scientific innovation and teams dedicated to improving patient lives.